Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,367 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cellular Senescence and Anti-Cancer Therapy.
You J, Dong R, Ying M, He Q, Cao J, Yang B. You J, et al. Curr Drug Targets. 2019;20(7):705-715. doi: 10.2174/1389450120666181217100833. Curr Drug Targets. 2019. PMID: 30556499 Review.
LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.
Cao J, Dong R, Jiang L, Gong Y, Yuan M, You J, Meng W, Chen Z, Zhang N, Weng Q, Zhu H, He Q, Ying M, Yang B. Cao J, et al. Among authors: you j. Cancer Immunol Res. 2019 Feb;7(2):292-305. doi: 10.1158/2326-6066.CIR-18-0145. Epub 2018 Nov 20. Cancer Immunol Res. 2019. PMID: 30459152
Correction: LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.
Cao J, Dong R, Jiang L, Gong Y, Yuan M, You J, Meng W, Chen Z, Zhang N, Weng Q, Zhu H, He Q, Ying M, Yang B. Cao J, et al. Among authors: you j. Cancer Immunol Res. 2024 Feb 2;12(2):275. doi: 10.1158/2326-6066.CIR-23-0983. Cancer Immunol Res. 2024. PMID: 38303655 No abstract available.
RIPK2: a promising target for cancer treatment.
You J, Wang Y, Chen H, Jin F. You J, et al. Front Pharmacol. 2023 May 30;14:1192970. doi: 10.3389/fphar.2023.1192970. eCollection 2023. Front Pharmacol. 2023. PMID: 37324457 Free PMC article. Review.
5,367 results